Comparison of canagliflozin and teneligliptin on energy intake and body weight in Japanese patients with Type 2 diabetes: a subanalysis of the CANTABILE study.

BMC Endocr Disord · 2024 · PMC11331643 · PMID 39160513

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The results showed a trend toward greater change in the group with a pre-treatment FIB-4 index of 1.3 or greater compared to those with a pre-treatment FIB-4 index of less than 1.3 (-0.28 ± 0.80 and -0.03 ± 0.19 p = 0.0556).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.